19 related articles for article (PubMed ID: 15142566)
1. DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods.
Gilbert KM; Boos TL; Dersch CM; Greiner E; Jacobson AE; Lewis D; Matecka D; Prisinzano TE; Zhang Y; Rothman RB; Rice KC; Venanzi CA
Bioorg Med Chem; 2007 Jan; 15(2):1146-59. PubMed ID: 17127069
[TBL] [Abstract][Full Text] [Related]
2. Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry.
Kalaba P; Pacher K; Neill PJ; Dragacevic V; Zehl M; Wackerlig J; Kirchhofer M; Sartori SB; Gstach H; Kouhnavardi S; Fabisikova A; Pillwein M; Monje-Quiroga F; Ebner K; Prado-Roller A; Singewald N; Urban E; Langer T; Pifl C; Lubec J; Leban JJ; Lubec G
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759815
[TBL] [Abstract][Full Text] [Related]
3. Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities.
Froimowitz M; Taboada R; Poulos ZJ; Rainone DJ; Imler GH; Gardner EL; Kelley CJ
ACS Omega; 2023 Oct; 8(39):35738-35745. PubMed ID: 37810691
[TBL] [Abstract][Full Text] [Related]
4. Syntheses of novel diphenyl piperazine derivatives and their activities as inhibitors of dopamine uptake in the central nervous system.
Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem; 2003 Apr; 11(8):1621-30. PubMed ID: 12659747
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
[TBL] [Abstract][Full Text] [Related]
6. Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem; 2003 Sep; 11(18):3953-63. PubMed ID: 12927856
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246
[TBL] [Abstract][Full Text] [Related]
8. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine.
Hsin LW; Dersch CM; Baumann MH; Stafford D; Glowa JR; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2002 Mar; 45(6):1321-9. PubMed ID: 11882001
[TBL] [Abstract][Full Text] [Related]
9. Efficient asymmetric syntheses, determination of absolute configurations and biological activities of 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3-(phenylamino)propyl]piperazine as a novel potent dopamine uptake inhibitor in the central nervous system.
Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem; 2004 Jun; 12(11):3069-78. PubMed ID: 15142566
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter as target for drug development of cocaine dependence medications.
Dutta AK; Zhang S; Kolhatkar R; Reith ME
Eur J Pharmacol; 2003 Oct; 479(1-3):93-106. PubMed ID: 14612141
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
